Predictors of Micrometastases in Patients with Barcelona Clinic Liver Cancer Classification B Hepatocellular Carcinoma.

about

Predictors of Micrometastases in Patients with Barcelona Clinic Liver Cancer Classification B Hepatocellular Carcinoma.

Item

http://www.wikidata.org/entity/Q42129377

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Predictors of Micrometastases ...... on B Hepatocellular Carcinoma.

@en

Predictors of Micrometastases ...... on B Hepatocellular Carcinoma.

@nl

type

Item

label

Predictors of Micrometastases ...... on B Hepatocellular Carcinoma.

@en

Predictors of Micrometastases ...... on B Hepatocellular Carcinoma.

@nl

prefLabel

Predictors of Micrometastases ...... on B Hepatocellular Carcinoma.

@en

Predictors of Micrometastases ...... on B Hepatocellular Carcinoma.

@nl

P1476

Predictors of Micrometastases ...... on B Hepatocellular Carcinoma.

@en

P2093

Suk Won Suh

http://www.w3.org/2001/XMLSchema#string

Yoo Shin Choi

http://www.w3.org/2001/XMLSchema#string

P2860

A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016

Management of hepatocellular carcinoma: An update

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire.

Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma.

Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization.

Prognostic prediction in patients with hepatocellular carcinoma.

Barcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection?

P304

737-742

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3349/YMJ.2017.58.4.737

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28540985

http://www.w3.org/2001/XMLSchema#string

P932

5447103

http://www.w3.org/2001/XMLSchema#string